DUBLIN--(BUSINESS WIRE)--The "Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets" report has been added to ResearchAndMarkets.com's offering.
The global market for radiation therapy products and radiopharmaceuticals is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.
This report analyzes the global market for radiation therapy products (systems, software and services) and radiopharmaceuticals, in terms of quantitative and qualitative data, to help readers develop assess the market, business/growth strategies, and make informed business decisions regarding radiation therapy products and services and radiopharmaceuticals. The research team estimates market data for 2023 (the base year) and forecasts values for 2024 through 2029.
Population and human life expectancy are increasing globally, spurring more chronic conditions and life-threatening diseases. A sedentary lifestyle, obesity and a lack of physical activity have further worsened the situation, leading to the increased importance of medical treatments and interventions. Despite incredible improvements in the field of medicine in the last few decades, an unmet need remains for the diagnosis, prevention, and treatment of aggressive ailments such as cardiovascular diseases, central nervous system disorders and cancer.
Since the discovery of radioactivity, it has been observed that radiation can play a role in the treatment of several diseases. Radiopharmaceuticals are a type of radioactive drug internally administered and intended to diagnose and treat diseases. Radiopharmaceuticals are now a vital part of the healthcare industry, as they can identify several disease processes much earlier than other diagnostic tests.
Applications of radiopharmaceuticals are rising significantly in the fields of neurology, oncology, cardiology and other medical specialties, such as gastroenterology, endocrinology and nephrology, for therapeutic and diagnostic purposes. Radiopharmaceuticals have also become a necessary part of personalized medicine. The market for therapeutic radiopharmaceuticals is anticipated to grow at a steep rate in the coming years due to growing applications and increased demand.
Growing acceptance and utilization of nuclear medicine scans (i.e., PET and SPECT) and better availability of radiopharmaceuticals due to a growing number of cyclotrons have significantly further contributed to growth in the radiopharmaceutical industry.
Innovative technological devices leading to early and accurate diagnoses, increased awareness of radiopharmaceuticals among patients and physicians and new regulatory approvals of radiopharmaceuticals are other major driving forces for the global radiopharmaceutical market. Furthermore, rising incidences of different types of cancers across the globe are considered a significant driver behind the growth of radiopharmaceuticals and therapeutics.
Industry growth drivers, restraints and opportunities in the radiation therapy and radiopharmaceutical market are also discussed. The report also reports on the competitive landscape of radiation therapy products, radiopharmaceutical markets and emerging trends. The latest new products, acquisitions, and collaborations related to the radiation therapy and radiopharmaceutical markets are also covered.
Report Includes
- 51 data tables and 39 additional tables
- An overview of the global market for radiotherapy, radiopharmaceuticals and nuclear medicines
- Analysis of global market trends, featuring historical revenue data for 2021-2023, estimated figures for 2024, forecasts for 2025, and projected CAGRs through 2029
- Identification of new opportunities, challenges and technological changes in the industry and a market share analysis by segment, product type, technology type, application, production method, and region
- Examination of the present and future strategies of companies in the market, including radiopharmaceuticals for both diagnostic and therapeutic purposes
- Discussion of the applications for positron emission tomography (PET) and single photon emission computed tomography (SPECT)
- Evaluation of market opportunities for external beam radiation therapy, internal radiation therapy and systemic radiotherapy
- Analysis of the current market trends and forecast, R&D activity, product launches and regulatory elements
- Analysis of the key companies' market shares, mergers & acquisitions, joint ventures and collaborations
- Profiles of the major players in the market, including Accuray Inc., Cardinal Health, Elekta, Novartis AG, and Siemens Healthineers AG
Company Profiles
- Accuray Inc.
- Cardinal Health
- Curium
- Elekta
- GE Healthcare
- Lantheus
- Novartis AG
- Siemens Healthineers AG
Key Topics Covered:
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Radiopharmaceuticals
- Radiation Therapy
Chapter 3 Market Dynamics
- Radiotherapy Market Drivers
- Rising Prevalence of Cancer
- Early Screening
- Advances in Radiation Therapy Planning and Delivery Systems
- Increasing Demand in Developing Regions
- Applications Beyond Oncology
- Radiotherapy Market Restraints
- Shortage of Skilled Professionals
- Limited Effectiveness against Metastatic Cancer
- Trends in Radiotherapy Market
- Growing Use of Advanced Imaging and Hypofractionation
- Adaptive Radiation Therapy
- Radiopharmaceutical Market Drivers
- Rising Prevalence of Chronic Diseases
- Focus on Early Diagnosis and Screening
- Precision Medicine
- Nuclear Imaging Technologies
- Increasing Investments
- Radiopharmaceutical Market Restraints
- Manufacturing and Supply Chain Issues
- Infrastructure and Specialized Imaging Equipment Requirements
- Trends in the Radiopharmaceutical Market
- Theranostics
- PET/MRI Hybrid Imaging
Chapter 4 Emerging Technologies and Developments
- Emerging Technologies in Radiation Therapy
- Artificial Intelligence
- Online Adaptive Radiation Therapy
- MR-Linac
- FLASH Radiation Therapy
- Emerging Technologies in Radiopharmaceuticals
- Targeted Alpha Therapy
Chapter 5 Market Segmentation Analysis
- Segmentation Breakdown
- Radiation Therapy Market, by Product Type
- Radiation Therapy Market, by Technology Type
- External Beam Radiation Therapy
- EBRT by Technique Type
- EBRT, by System Type
- EBRT, by Application
- Internal Beam Radiation Therapy
- IBRT, by Technique Type
- IBRT, by Product Type
- IBRT, by Application
- Radiation Therapy Market, by Region
- Radiopharmaceuticals Market, by Product Type
- Diagnostic Radiopharmaceuticals
- Therapeutic Radiopharmaceuticals
- Radiopharmaceuticals Market, by Application
- Oncology
- Cardiology
- Neurology
- Other Applications
- Radiopharmaceuticals Market, by Production Method
- Nuclear Reactors
- Cyclotrons
- Radionuclide Generators
- Market Size and Forecast
- Geographic Breakdown
- Radiopharmaceuticals Market, by Region
Chapter 6 Competitive Intelligence
- Leading Radiotherapy Device Manufacturers
- Leading Companies in Radiopharmaceuticals
Chapter 7 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/ga08uq
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
